Clinical Trials Browser

Phase 1 × INDUSTRY × Metastatic Castration-resistant Prostate Cancer × Clear all

NCT06052306 2026-03-02

A Study to Learn How Safe the Study Treatment Actinium-225-macropa-pelgifatamab (BAY3546828) is, How it Affects the Body, How it Moves Into, Through and Out of the Body, and About Its Anticancer Activity in Participants With Advanced Metastatic Castration-resistant Prostate Cancer (mCRPC)

Phase 1 Active not recruiting

Metastatic Castration-resistant Prostate Cancer

NCT07244341 2026-02-04

A Study of Valemetostat (DS-3201b) in Combination With Darolutamide in Metastatic Castration Resistant Prostate Cancer (mCRPC)

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT06492122 2026-01-29

ProTACT

Phase 1 Recruiting

Metastatic Castration-resistant Prostate Cancer

NCT05252364 2024-03-21

A Study to Assess the Safety, Pharmacokinetics, and Anti-Tumor Activity of Oral HP518 in Patients With Metastatic Castration-Resistant Prostate Cancer

Phase 1 Completed

Metastatic Castration-resistant Prostate Cancer

NCT05533203 2023-01-23

Safety of Prodencel in the Treatment of Metastatic Castration-resistant Prostate Cancer (mCRPC)

Phase 1 Unknown

Metastatic Castration-resistant Prostate Cancer

NCT04853498 2021-11-24

A Study to Evaluate the Tolerance and Pharmacokinetics of TQB3720 Tablets

Phase 1 Unknown

Metastatic Castration-resistant Prostate Cancer